Quebec Denies $27,000 Monthly Brain Cancer Treatment Funding, Patient Feels Abandoned
A 31-year-old man from Nominingue, Quebec, Samuel Rochon, is battling a challenging situation as he confronts a brain cancer diagnosis. Recently, Quebec’s government denied funding for a promising treatment costing $27,000 monthly. This refusal has left Rochon feeling abandoned and insulted. He stated, “It’s as if my life has a monetary value.”
Details of the Case
Rochon has been diagnosed with a grade 4 glioblastoma, the most aggressive form of brain cancer. Since 2016, he has faced numerous health challenges, including multiple surgeries, followed by 25 sessions of chemotherapy and radiotherapy. Despite the dire prognosis, he has survived over eight years, considerably exceeding the five-year survival rate, which is below 5% for this type of cancer.
Recent Health Developments
On January 1, 2025, Rochon experienced a recurrence of cancer, requiring additional surgery. His medical condition remains stable, but he acknowledges future recurrences are inevitable. To raise funds for his treatment, he launched a fundraising campaign on GoFundMe, aiming for a goal of CAD 300,000. As of yesterday, he had already raised a third of this amount.
The Treatment in Question
The treatment that Rochon is pursuing is the Optune device, which has shown to prolong survival in patients with glioblastoma. However, it is not reimbursed by Quebec’s health insurance due to its non-recognition by the National Institute of Excellence in Health and Social Services (INESSS). Dr. Sarah Lapointe, Rochon’s oncologist, insists that the device is an effective and authorized treatment.
Funding Concerns and Responses
- Monthly Cost: $27,000
- Fundraising Campaign Goal: $300,000
- Current Funds Raised: One-third of the goal
Despite INESSS acknowledging the innovation of the Optune device, there are reservations regarding its implementation in Quebec’s healthcare system. A reevaluation of the device could occur at the request of the Quebec Ministry of Health and Social Services (MSSS).
A Life Beyond the Diagnosis
Rochon’s fight against cancer has not defined his life. He has lived passionately, traveling to 22 countries and participating in a half-marathon during chemotherapy. Born with a congenital malformation, he had his left leg amputated at the age of six and subsequently embraced sports.
Plans for the future include establishing a foundation to help children in his community and aspirations of fatherhood. With around 40 planned trips ahead, he remains determined to live life to the fullest.
